A Study to Evaluate the Real-world Experience and Satisfaction Associated With Ofatumumab
Clinical trial NCT07504783 · COMPLETED
Trial details
- NCT number
- NCT07504783
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2026-01-22
- Primary completion
- 2026-04-30
- Enrollment
- 261
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.